Drug Utilization Review (DUR) Board
The Department of Human Services has appointed the Drug Utilization Review Board to promote patient safety by review of outpatient drug prescribing and dispensing in the Medical Assistance program.
The Department's drug use review program consists of:
- Prospective Drug Use Review (ProDUR)
- Retrospective Drug Use Review (RetroDUR)
DUR Board Meeting Information
Upcoming Meetings
Date:
Wednesday, November 3, 2021, 9:00am-12:00pm
Location:
The November DUR Board meeting will be held virtually.
Register for the Webinar:
Register for the DHS DUR Board meeting on Wednesday, November 3, 2021 at 9:00am EDT: https://attendee.gotowebinar.com/register/8197679838490261520
After registering, you will receive a confirmation email containing information about joining the webinar.
Agenda
Past Drug Utilization Review Board Meetings
Review the Drug Utilization Review Board By-Laws
The DUR Board is comprised of DHS medical directors, external physicians, pharmacists, consumer advocates, and specialists as needed.
| Name | Specialty | External Member * | Internal Member ** |
| Ivonne Acrich, MD | OMAP Medical Director Child/Adolescent Psychiatrist | | X |
| Dale Adair, MD, FAPA | Offices of Mental Health & Substance Abuse Services Medical Director | X | |
| Lawrence Appel, MD, SFHM | Office of Long Term Living Medical Director | X | |
| Cheston Berlin, Jr., MD | Pediatrician | X | |
| Sevdalina Boshnakov, MD | OMAP Pharmacy Medical Director | | X |
| Tony Byler, MD | PerformCare Psychiatrist | X | |
| Terri Cathers, PharmD, Chair (tie-breaker vote only) | OMAP Pharmacy Director | | X |
| Michael Colvin, PharmD | AmeriHealth Caritas & Keystone First HealthChoices & Community HealthChoices Pharmacist | X | |
| Sharon Connor, PharmD | Academic Pharmacist | X | |
| Oluwatoyin Fadeyibi, PharmD | Community Behavioral Health Pharmacist | X | |
| Andrea Fox, MD | Internist | X | |
| James Hancovsky, RPh, MBA | UnitedHealthcare Pharmacist | X | |
| Kristin Hoover, PharmD (non-voting) | OMAP Clinical Pharmacist | | X |
| Paula Horn, PharmD | Clinical Pharmacist | X | |
| Rosemary Keffer, MD | Ad Hoc Adult Psychiatrist | X | |
| David Kelley, MD | OMAP Chief Medical Officer | | X |
| Renee Licwinko, RPh | Gateway Health Plan Pharmacist | X | |
| Hannah Livengood, PharmD | Health Partners of Philadelphia Pharmacist | X | |
| Meghan McNelly, PharmD | PA Health & Wellness Pharmacist | X | |
| Geoffrey Neimark, MD | Community Care Behavioral Health Psychiatrist | X | |
| Natalie Nkurunziza, PharmD | Aetna Better Health Pharmacist | X | |
| Louis Parrott Jr., MD, PhD | Magellan Healthcare Psychiatrist | X | |
| Mirza Perez, PharmD | Clinical Pharmacist | X | |
| Adam Raphael Rom, MD | Family Practitioner | X | |
| Amy Saracino, MD | Ad Hoc Adult Psychiatrist, OMHSAS | | X |
| Jeanne Spencer, MD | Family Practitioner | X | |
| Kevin Szczecina, RPh | Geisinger Health Plan Pharmacist | X | |
| Mahmood Usman, MD | Beacon Health Options Psychiatrist | X | |
| Margery Wasko, MD | OMAP Medical Director | | X |
| Lloyd Wertz | Consumer/Family Advocate | X | |
| Lauren Zandier, PharmD | UPMC For You Pharmacist | X | |
* - External Members are not employed by the Department
** - Internal Members are employed by or under contract with the Department on a full or part-time basis
Effective October 22, 2020 / Last modified September 16, 2021